Endometrial intraepithelial neoplasia overview

Endometrial intraepithelial neoplasia Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Endometrial intraepithelial neoplasia from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
Staging
Other Diagnostic Studies
Treatment
Surgery
Case Studies
Case #1
Endometrial intraepithelial neoplasia overview On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Endometrial intraepithelial neoplasia overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Endometrial intraepithelial neoplasia overview
CDC on Endometrial intraepithelial neoplasia overview
Endometrial intraepithelial neoplasia overview in the news
Blogs on Endometrial intraepithelial neoplasia overview</small>
Directions to Hospitals Treating Endometrial intraepithelial neoplasia
Risk calculators and risk factors for Endometrial intraepithelial neoplasia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Endometrial Intraepithelial Neoplasia, (EIN) is a premalignant lesion of the uterine lining that predisposes to endometrioid endometrial adenocarcinoma. It is composed of a collection of abnormal endometrial cells, arising from the glands that line the uterus, which have a tendency, over time to progress to the most common form of uterine cancer - endometrial adenocarcinoma, endometrioid type.

Diagnosis of EIN lesions is of clinical importance because of the increased risk of coexisting (39% of women with EIN will be diagnosed with carcinoma within one year) or future (the long term endometrial cancer risk is 45 times greater for a woman with EIN compared to one with only a benign endometrial histology) endometrial cancer. Diagnostic terminology is that used by pathologists, physicians who diagnose human disease by examination of histologic preparations of excised tissues. Critical distinctions in EIN diagnosis are separation from benign conditions such as benign endometrial hyperplasia (a field effect in endometrial tissue caused by excessive stimulation by the hormone estrogen), and cancer.